Seoul, South Korea

Sun-Mo Oh

This inventor holds 1 USPTO granted patent. Top assignees: Mogam Biotechnology Institute, Neurotech Pharmaceuticals Co., Ltd.. Active years: 2008.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sun-Mo Oh: Innovator in Expression Vectors for Animal Cells

Introduction

Sun-Mo Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of expression vectors for animal cells. His innovative work has the potential to enhance the production of recombinant proteins, which are crucial for various applications in medicine and research.

Latest Patents

Sun-Mo Oh holds a patent for an expression vector designed for animal cells. This invention, known as the pMS vector, pSG vector, and pMSG vector, incorporates the human β-globin 5' MAR complementary sequence and the transcription termination site of the gastrin gene. The expression system utilizing this vector can successfully produce recombinant proteins in various animal cells, resulting in proteins with unique structures and functions. He has 1 patent to his name.

Career Highlights

Throughout his career, Sun-Mo Oh has worked with notable organizations in the biotechnology sector. He has been associated with the Mogam Biotechnology Institute and Neurotech Pharmaceuticals Co., Ltd. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Sun-Mo Oh has collaborated with esteemed colleagues, including Jong-Mook Kim and Jung-Seob Kim. These partnerships have furthered his research and development efforts in biotechnology.

Conclusion

Sun-Mo Oh's contributions to the field of biotechnology, particularly through his innovative expression vectors, have the potential to significantly impact the production of recombinant proteins. His work exemplifies the importance of innovation in advancing scientific research and applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…